16 minute read

EXHIBITOR PROFILES

EXHIBITOR PROFILE AL NAWRAS MEDI-LAB SUPPLIES

Stand Number: B09 United Arab Emirates https://www.alnawrasmls.com/ Al Nawras provides innovative solutions for its partners in the health care and life science research field. Our vision is to develop the scientific and medical research to be able to integrate sustainability into the sector’s economy and business model. Our mission is to provide innovative solutions for our clients in the health care and life science sector, with cooperation with our partners to offer technological advancements that help facilitate their work, whilst having a solid grasp of what they do. Product Categories Digital Health Epigenetics Molecular Diagnostics Next-Generation Sequencing (NGS) Other

Advertisement

ANTEGENES

Stand Number: D01A Estonia www.antegenes.com Antegenes® (est. 2018) is an ISO 13485 certified health-tech company and a registered healthcare services provider (laboratory services;medical genetics, oncology) in Estonia. Antegenes is an international pioneer of precision preventive medicine, aiming to use personal genetic information to reduce the severity and mortality due to common complex diseases (cancers, cardiovascular disease, diabetes, etc). Antegenes develops and implements advanced genetic tests based on polygenic risk scores technology to enable precision prevention. Antegenes has brought four innovative CE-marked genetic tests (in vitro medical devices, 98/79/EC) into clinical use. Our tests are for breast cancer, prostate cancer, colorectal cancer, and skin melanoma. Based on our tests we have created and implemented genetics-based precision prevention programs. We inform individuals and their doctors about their genetic disease risks and provide actionable medical recommendations that reduce the likelihood, severity and mortality of common cancers and other complex diseases. Antegenes’ products are created scientifically with laboratory and clinical validity and clinical usefulness, which makes them usable in healthcare by a broad range of healthcare professionals and institutions. Products are based on peer-reviewed international research and have been evaluated and validated using anonymized population data of the UK Biobank and Estonian Biobank. Our services include development and creation of genetics-based personalized cancer screening programs for different clinical settings and populations. Product Categories Molecular Diagnostics Precision Oncology

BGI

Stand Number: A01 China https://www.bgi.com/global A world leader in scientific and precision medicine services that: • provides leading research and precision medicine solutions to science institutes, enterprises, medical facilities and healthcare organizations • works to advance technological innovation, reduce birth defects, fight tumors and protect against serious illness • promotes precision medicine to cure infections Product Categories Next-Generation Sequencing (NGS) Precision Oncology

BIS RESEARCH INC.

Stand Number: D06 United States https://bisresearch.com/ BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends which can disrupt the market dynamics in the near future. We publish more than 200 market intelligence studies annually that focus on several deep technology verticals. Our strategic market analysis emphasizes on market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management. We offer syndicate as well as custom studies and expert consultations to firms, providing them specific and actionable insights on novel technology markets, business models, and competitive landscape. Our BIS Healthcare division offers market intelligence for precision medicine, medical devices, digital health, life sciences, robotics and imaging, and other emerging healthcare technologies, covering the entire industry spectrum. In the past 3 years, BIS Healthcare has published more than 70 reports

under the precision medicine banner. Additionally, BIS Research had been nominating Top 25 Voices in Precision Medicine on its Insight Monk platform in 2019 and 2020. Product Categories AI & Big Data Chronic Disease Digital Health Drug Discovery Epigenetics Immunology Molecular Diagnostics Next-Generation Sequencing (NGS) Pharmacogenomics (PGX) Precision Oncology Rare and Orphan Disease Targeted Therapeutics Other

CEGAT GMBH

Stand Number: A02B Germany www.cegat.com CeGaT is a global provider of genetic analyses for a wide range of medical, research, and pharmaceutical applications. Founded in 2009 in Tübingen, Germany, the company combines stateof-the-art sequencing technology with medical expertise - with the aim of identifying the genetic causes of diseases and supporting patient care. For researchers and pharmaceutical companies, CeGaT offers a broad portfolio of sequencing services and tumor analysis. CeGaT generates the data basis for clinical studies and medical innovations and drives science forward with its own insights. The owner-managed company stands for independence, comprehensive personal customer service, and outstanding quality. CeGaT‘s laboratory is accredited according to CAP/CLIA, DIN EN ISO 15189, and DIN EN ISO 17025, and thus meets the highest international standards. In order to obtain firstclass results, all processes are carried out in-house under scientific supervision.” Product Categories Epigenetics Immunology Molecular Diagnostics Next-Generation Sequencing (NGS) Pharmacogenomics (PGX) Precision Oncology Rare and Orphan Disease Targeted Therapeutics

DIGINOVA HEALTH SOLUTION

Stand Number: BO1B United Arab Emirates https://www.diginovahealth.com Diginova Health Solutions, based in Dubai, empower proven and enterprise-ready digital health technologies by providing commercial and technical support, developing regional proof-ofconcept projects, and building essential partnerships. It provides services to international and regional companies to amplify the impact of their GCC expansion plans;presents the investors, who are eager to invest in digital health, with unique investment opportunities. Diginova aims to improve outcomes by educating people on diseases before they become patients through the execution of digitally enabled solutions that move healthcare from the hospital into the home, helping vulnerable groups to live better life. The fastchanging healthcare environment is increasing the demand of advanced technology and innovative care models. It addresses the challenges facing the current healthcare system by working with its partners to implement winning strategies. Diginova is dedicated to introducing change and adaptability in highly dynamic environments. It integrates different sectoral interests to build sustainable incentives for innovative service provisions, fostering collaboration across the healthcare value chain to encourage stakeholder alignment.” Product Categories AI & Big Data Chronic Disease Digital Health Molecular Diagnostics Pharmacogenomics (PGX) Precision Oncology Targeted Therapeutics Other

G42 HEALTHCARE

Stand Number: A05 United Arab Emirates https://www. g42healthcare.ar

G42 Healthcare, a leading healthtech company, is on a mission to develop a world-class healthcare sector in the UAE and beyond, by harnessing data and advanced medical technologies to unlock the potential of personalised and preventive care and transforming the traditional healthcare ecosystem.

At the forefront in the battle against COVID-19, we established Biogenix Labs, the UAE’s first COVID-19 accredited large-scale throughput laboratory and facilitated the world’s first Phase III trials for an inactivated vaccine against COVID-19. The 4Humanity trials enrolled over 43,000 volunteers from 125+ nationalities across the pan-Arab region. Subsequently, we supported the UAE’s healthcare authorities implement a national vaccination drive. We continue to employ advanced AI techniques and vast computing resources to accelerate the detection of COVID-19 and conduct research into new vaccines and drug therapies. Product Categories Precision Oncology Rare and Orphan Disease Chronic Disease Molecular Diagnostics AI & Big Data Next-Generation Sequencing (NGS) Digital Health Targeted Therapeutics

Stand Number: B13 United Arab Emirates

www.genetricsinc.com Genomics and Genetrics – Your Trusted Partner in Personalized Molecular Diagnostics Genetrics with more than 12 years of operations in UAE, is one of the fastest growing integrated Genomics Solution provider for both Molecular Diagnostics and Research customers in the Middle East in terms of Products and solutions. Representing Cutting edge technologies from Personalized qPCR solutions, MLPA kits, NGS library Prep kits to Optical Genome Mapping for SVs and Large Indels that are not possible by other NGS technologies. Genetrics skilled team of Product specialist, researchers, Bioinformatics and qualified Engineers can duly support our Genomic clients in terms of method development, Optimization, Training and service Support for their solutions matching to the factory standards. Product Categories Precision Oncology Pharmacogenomics (PGX) Molecular Diagnostics Next-Generation Sequencing (NGS) AI & Big Data Immunology Epigenetics

GULF SCIENTIFIC CORPORATION

Stand Number: B16 United Arab Emirates https://gulf-scientific.com/ Founded in 1990, Gulf Scientific Corporation (GSC) is headquartered in Dubai, United Arab Emirates with four regional offices and a number of distribution outlets across the Middle East. GSC has established strategic partnerships with market leaders that include, among others, Merck, PerkinElmer, Thermo Fisher Scientific’s Applied Biosystems, and Waters to ensure that clients have the best available resources to meet their critical laboratory needs. With an unrivaled support structure that includes manufacturer-certified service and training centers, GSC is the preferred choice for companies in a wide range of industries including, clinical, pharmaceutical, food and beverage, oil and gas, environmental, and others. In addition to a network of distinguished local agents, the GSC sales and service teams of over 200 professionals operates in various countries throughout the Middle East to ensure close reach to any laboratory. Our Training Centre, which boasts three purpose-built laboratories and two lecture halls, provides firstrate facilities to train scientists and technicians from across the region. Additionally, our headquarters in Dubai feature an extensive warehouse and operations hub that offers innovative logistics solutions for our partners and clients alike. For over thirty years, Gulf Scientific Corporation has demonstrated its unwavering commitment to the development of the scientific community across the Middle East. Product Categories Chronic Disease Drug Discovery Immunology Pharmacogenomics (PGX) Precision Oncology Rare and Orphan Disease Targeted Therapeutics

IGENOMIX

Stand Number: B03 United Arab Emirates https://www.igenomix.net/ A worldwide reference company in reproductive services and diagnostic genetic services. Product Categories Molecular Diagnostics Next-Generation Sequencing (NGS) Precision Oncology Rare and Orphan Disease

ILLUMINA

Stand Number: B07 United Kingdom www.illumina.com For more than 20 years, Illumina has aspired to improve human health by unlocking the power of the genome. Our initial products enabled researchers to explore DNA in an entirely new way. Now, with more than 3400 patents worldwide and our sequencing-by-synthesis technologybeing used to generate over 90% of the world’s sequencing data, we are leading the way, one genomic breakthrough at a time. While the rate of progress continues to accelerate exponentially as we move towards precision medicine, we have only just begun to discover the true impact of genomics in areas we touch, including oncology, reproductive health, genetic disease, agriculture, microbiology, and beyond. This realization, and the discoveries we know lie ahead, are what inspire us to push the boundaries of our imagination and drive innovation. Product Categories Epigenetics Immunology Molecular Diagnostics Next-Generation Sequencing (NGS) Precision Oncology Rare and Orphan Disease Other

INDUS HEALTH PLUS

Stand Number: B01A India www.indushealthplus.com Indus Health Plus has been trailblazing the Preventive Healthcare and Wellness industry since its inception in 2000. With the aim of making quality healthcare Available, Accessible and Affordable, Indus Health Plus has taken its services across the globe. Indus has a range of genetic products

under the brand - DNAwise;to give a complete analysis of your body type, health risks, and a recommended lifestyle. Product Categories Pharmacogenomics (PGX)

INTEGRATED GULF BIOSYSTEMS

Stand Number: C06 United Arab Emirates https://igbiosystems.com/ Integrated Gulf Biosystems (IGB) is a partner of choice for Life Science and Clinical Genomic Solutions in the Middle East (Kingdom of Saudi Arabia, United Arab Emirates, Qatar, Bahrain and Libya). Since its inception in 1999, IGB has differentiated itself through exemplary Support (Service and Application), Workflow solutions and good sales support. IGB are channel partners for Life Science giants such as Thermofisher Scientific, Hamilton (Robotics and Storage), Molecular Devices, and others. To provide Molecular and Genomic solutions for inherited and infectious disease diagnostics we feature validated clinical solutions from Fast-track Diagnostics, Premaitha Health, DNA Genotek, BAG Healthcare and Elucigene Diagnostic. Product Categories Epigenetics Immunology Molecular Diagnostics Next-Generation Sequencing (NGS) Precision Oncologys

INVENTION VISION MEDICAL REQUISITES TRADING L.L.C

Stand Number: C11 United Arab Emirates www.ivision.com.co We are distributor company, based in Dubai. We represent Medical Diagnostic solutions and temperature control devices across the GCC market. We join hands with top class manufacturing companies across the globe, who represent very unique technology and solutions for medical, pharmaceutical, hospital and diagnostic industries across GCC countries. Product Categories Epigenetics Molecular Diagnostics Pharmacogenomics (PGX) Precision Oncology

LABOSHOP

Stand Number: A04 United Arab Emirates www.laboshop.ae LaboShop is your go-to platform in MENA for everything related to molecular biology including tech products, premium services and news. Product Categories Digital Health Molecular Diagnostics Other

LEADER LIFE SCIENCES

Stand Number: C01 United Arab Emirates https://leaderlifesciences.com/ With more than a decade of excellence in the field of healthcare, medical sciences and education, Leader Healthcare Group incepted Leader Life Sciences in 2020 to serve the scientific community and facilitate breakthroughs by introducing innovative solutions and automation technologies across analytical sciences, biofabrication, animal research, histopathology, precision medicine, and OMICS. The impact-driven leadership team, headed by visionary Mr. Sukhdeep Sachdev, ensured the establishment of a knowledge-oriented culture that drives the team to achieve greatness and targeted milestones. Leader Life Sciences holds immense pride to be established as a onestop scientific solution provider with exemplary services and products dedicated to playing a crucial part in contributing to healthy urban life with cutting-edge care. From drug discovery to clinical trials to pharma to research & development to diagnostics, explore a metaverse of comprehensive scientific solutions that aims to disrupt the world of precision medicine with Leader Life Sciences at Stand C-01. Visit us from May 24-25, 2022, at PrecisionMed Expo and Summit 2022 from 10 am to 5 pm. Product Categories AI & Big Data Digital Health Drug Discovery Epigenetics Immunology Molecular Diagnostics Next-Generation Sequencing (NGS) Pharmacogenomics (PGX) Precision Oncology Targeted Therapeutics Other

EXHIBITOR PROFILE LIFEGEN

Stand Number: A03B United Arab Emirates www.lifegenhealth.com At Lifegen, we proudly offer a multitude of innovative cancer solutions for screening, diagnosis, treatment guidance and follow up. Our cancer screening test, is the only FDA approved blood test for early screening and detection of Breast, Prostate and 70+ types of cancer which was granted the “Breakthrough” designation this year;A revolutionary test that soon will be a practice changer globally. Product Categories Precision Oncology

MGI

Stand Number: B10 China https://en.mgi-tech.com/ MGI Tech Co., Ltd. (referred to as MGI) is committed to building core tools and technology to lead life science through intelligent innovation. With a focus on R&D, production and sales of DNA sequencing instruments, reagents, and related products, MGI provides real-time, panoramic, and fulllife-cycle equipment and systems for precision medicine, precision agriculture, precision healthcare and other relevant industries. MGI is a leading producer of clinical high-throughput gene sequencers, and its multi-omics platforms include genetic sequencing, medical imaging, and laboratory automation. As of December 31, 2020, MGI has 1,726 employees, and 32.79% of whom are R&D personnel. Founded in 2016, MGI operates in more than 70 countries and regions, serving more than 1000 customers. It has established scientific research and production bases, global training and service network in many countries and regions around the world. MGI is one of the companies in the world that have the ability to independent develop and massproduce clinical high-throughput gene sequencers. Providing realtime, comprehensive, life long solutions, its vision is to lead life science innovation. Product Categories Next-Generation Sequencing (NGS)

OLINK PROTEOMICS

Stand Number: B15 Sweden https://www.olink.com/ Olink offers an unmatched highmultiplex technique to identify actionable biomarkers, with a strong focus on the human plasma proteome. Using minimal sample volume we provide quantifiable results with high-throughput, exceptional sensitivity and specificity, with coverage across a broad dynamic range. Our mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology. We are committed to develop our offering and are continuously expanding our protein coverage for a growing number of biological processes and pathways. Olink is well-established in Europe (HQ Uppsala, Sweden) and the USA (HQ Boston, MA), with a rapidly developing presence across Asia. We also work with a growing number of core labs around the world offering analysis and support to an expanding global customer base. For more information, please visit www.olink.com Olink® is a registered trademark of Olink Proteomics AB. Product Categories AI & Big Data Chronic Disease Drug Discovery Immunology Pharmacogenomics (PGX) Precision Oncology Rare and Orphan Disease Targeted Therapeutics

OMNIGENE MEDICAL TECHNOLOGIES LTD.

Stand Number: B14 Malta genemt.com Omnigene Medical Technologies Ltd. is actively engaged in innovations promoting accurate and precise tests from low volume and difficult samples. The tests can be used in the clinic for patient surveillance, and in research laboratories to measure multiple analytes in a low volume or highly degraded material. The methodologies are versatile and can be used in various health areas, in research models, in archival material to minimise time lapse for validation of biomarkers, in liquid biopsies (circulating tumour cells and exosomes) and in clinical trials. We developed tests and optimised services in the areas of cancer testing, autoimmune disease, inflammatory diseases, dysbiosis and neurological conditions. The company also invests in development projects aimed to enhance existing technologies and to merge technologies towards specific aims. As a contract research organisation (CRO) we leverage our optimised methodologies to support the academic community and biotech companies to measure multiple analytes (DNA, RNA and proteins) in low-input and low quality material. Omnigene Medical Technologies Ltd also represents companies that offer high-end technologies for the academic research laboratories and promotes cutting edge technologies for early detection of disease and its progression. We specialise in emerging technologies, innovations, early detection of cancer, cancer progression, breast cancer, colorectal cancer, cervical cancer, lung cancer, gastric cancer, COVID-19 serology, vaccine surveillance, preclinical CRO, xMAP technology, multiplex assays, validation studies, liquid biopsies, exosome research, microbiome, and genetic services.

Product Categories Chronic Disease Epigenetics Immunology Molecular Diagnostics

SENGENICS

Stand Number: C08 United States www.sengenics.com Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, dataguided decision making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, therapeutic response prediction and development of companion diagnostics. Product Categories Drug Discovery Immunology Molecular Diagnostics Precision Oncology Other

SEQONE GENOMICS & GLOBAL DIAGNOSTIC SOLUTIONS

Stand Number: A02 France https://seqone.com/ https://gds-eg.com/ SeqONE Genomics is considered one of top leaders in Genetic data analysis and reporting in Europe and provide the shortest path from raw data to actionable results, The integrated genomic analysis solution delivers accurate results with increased efficiency and fast turnaround times Providing Diagnostics Solutions for: Rare and hereditary diseases, cancer predisposition, Somatic cancer diagnostics. Product Categories AI & Big Data Molecular Diagnostics Next-Generation Sequencing (NGS) Pharmacogenomics (PGX) Precision Oncology Rare and Orphan Disease Targeted Therapeutics Other

THERMO FISHER SCIENTIFIC

Stand Number: E05 United Kingdom www.thermofisher.com Thermo Fisher Scientific is the world leader in serving science. Customers worldwide trust our tools, services and solutions to help them accelerate innovation and enhance productivity. Together, we are making advancements that make a real difference. We do that by providing an unmatched combination of innovative technologies, purchasing convenience, and comprehensive support through product and service brands that include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Product Categories Next-Generation Sequencing (NGS) Precision Oncology Targeted Therapeutics

VERACYTE

Stand Number: C10 France https://io.veracyte.com/ Veracyte, formerly HalioDx, is a global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. Our immuno-oncology diagnostic products and services are used to guide cancer care and contribute to precision medicine in the era of immuno-oncology and combination therapies. The company provides a unique range of immune scoring solutions, including the Immunoscore® assay for assessing the immune contexture of a tumor. Immunoscore® in colon cancer is available as a CLIA or CE marked test to guide day-today oncologists’ decisions. Immunoscore® can be a diagnostic platform for many cancers, as immune response to tumor is a key hallmark of disease progression Product Categories Digital Health Immunology Precision Oncology

This article is from: